|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Muzny DM, Bainbridge MN, Chang K, Dinh HH,
Drummond JA, Fowler G, Kovar CL, Lewis LR, Morgan MB, Newsham IF,
et al Cancer Genome Atlas Network: Comprehensive molecular
characterization of human colon and rectal cancer. Nature.
487:330–337. 2012. View Article : Google Scholar
|
|
4
|
Fearon ER: Molecular genetics of
colorectal cancer. Annu Rev Pathol. 6:479–507. 2011. View Article : Google Scholar
|
|
5
|
Fu L and Lee CC: The circadian clock:
Pacemaker and tumour suppressor. Nat Rev Cancer. 3:350–361. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Takahashi JS, Hong HK, Ko CH and McDearmon
EL: The genetics of mammalian circadian order and disorder:
Implications for physiology and disease. Nat Rev Genet. 9:764–775.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sahar S and Sassone-Corsi P: Metabolism
and cancer: The circadian clock connection. Nat Rev Cancer.
9:886–896. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Straif K, Baan R, Grosse Y, Secretan B, El
Ghissassi F, Bouvard V, Altieri A, Benbrahim-Tallaa L and Cogliano
V; WHO International Agency For Research on Cancer Monograph
Working Group: Carcinogenicity of shift-work, painting, and
fire-fighting. Lancet Oncol. 8:1065–1066. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Innominato PF, Focan C, Gorlia T, Moreau
T, Garufi C, Waterhouse J, Giacchetti S, Coudert B, Iacobelli S,
Genet D, et al Chronotherapy Group of the European Organization for
Research and Treament of Cancer: Circadian rhythm in rest and
activity: A biological correlate of quality of life and a predictor
of survival in patients with metastatic colorectal cancer. Cancer
Res. 69:4700–4707. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Block KI, Block PB, Fox SR, Birris JS,
Feng AY, de la Torre M, Nathan D, Tothy P, Maki AK and Gyllenhaal
C: Making circadian cancer therapy practical. Integr Cancer Ther.
8:371–386. 2009. View Article : Google Scholar
|
|
11
|
Giacchetti S, Perpoint B, Zidani R, Le
Bail N, Faggiuolo R, Focan C, Chollet P, Llory JF, Letourneau Y,
Coudert B, et al: Phase III multicenter randomized trail of
oxaliplatin added to chronomodulated fluorouracil-leucovorin as
first-line treatment of metastatic colorectal cancer. J Clin Oncol.
18:136–147. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Giacchetti S: Chronotherapy of colorectal
cancer. Chronobiol Int. 19:207–219. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Focan C, Kreutz F, Graas M-P, Longrée L,
Focan-Henrard D, Demolin G and Moeneclaey N: Phase I - II study to
assess the feasibility and activity of the triple combination of
5-fluorouracil/folinic acid, carboplatin and irinotecan (CPT-11)
administered by chronomodulated infusion for the treatment of
advanced colorectal cancer. Final report of the BE-1603 study.
Pathol Biol (Paris). 61:e27–e31. 2013. View Article : Google Scholar
|
|
14
|
Gery S and Koeffler HP: The role of
circadian regulation in cancer. Cold Spring Harb Symp Quant Biol.
72:459–464. 2007. View Article : Google Scholar
|
|
15
|
Lee C, Etchegaray JP, Cagampang FR, Loudon
AS and Reppert SM: Posttranslational mechanisms regulate the
mammalian circadian clock. Cell. 107:855–867. 2001. View Article : Google Scholar
|
|
16
|
Reppert SM and Weaver DR: Coordination of
circadian timing in mammals. Nature. 418:935–941. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Antoch MP, Song EJ, Chang AM, Vitaterna
MH, Zhao Y, Wilsbacher LD, Sangoram AM, King DP, Pinto LH and
Takahashi JS: Functional identification of the mouse circadian
Clock gene by transgenic BAC rescue. Cell. 89:655–667. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu D, Potluri N, Lu J, Kim Y and
Rastinejad F: Structural integration in hypoxia-inducible factors.
Nature. 524:303–308. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Krugluger W, Brandstaetter A, Kállay E,
Schueller J, Krexner E, Kriwanek S, Bonner E and Cross HS:
Regulation of genes of the circadian clock in human colon cancer:
Reduced period-1 and dihydropyrimidine dehydrogenase transcription
correlates in high-grade tumors. Cancer Res. 67:7917–7922. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mazzoccoli G, Panza A, Valvano MR, Palumbo
O, Carella M, Pazienza V, Biscaglia G, Tavano F, Di Sebastiano P,
Andriulli A, et al: Clock gene expression levels and relationship
with clinical and pathological features in colorectal cancer
patients. Chronobiol Int. 28:841–851. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang Y, Hua L, Lu C and Chen Z: Expression
of circadian clock gene human Period2 (hPer2) in human colorectal
carcinoma. World J Surg Oncol. 9:1662011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Oshima T, Takenoshita S, Akaike M,
Kunisaki C, Fujii S, Nozaki A, Numata K, Shiozawa M, Rino Y, Tanaka
K, et al: Expression of circadian genes correlates with liver
metastasis and outcomes in colorectal cancer. Oncol Rep.
25:1439–1446. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yu H, Meng X, Wu J, Pan C, Ying X, Zhou Y,
Liu R and Huang W: Cryptochrome 1 overexpression correlates with
tumor progression and poor prognosis in patients with colorectal
cancer. PLoS One. 8:e616792013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhou F, He X, Liu H, Zhu Y, Jin T, Chen C,
Qu F, Li Y, Bao G, Chen Z, et al: Functional polymorphisms of
circadian positive feedback regulation genes and clinical outcome
of Chinese patients with resected colorectal cancer. Cancer.
118:937–946. 2012. View Article : Google Scholar
|
|
25
|
Lu H, Chu Q, Xie G, Han H, Chen Z, Xu B
and Yue Z: Circadian gene expression predicts patient response to
neoadjuvant chemoradiation therapy for rectal cancer. Int J Clin
Exp Pathol. 8:10985–10994. 2015.PubMed/NCBI
|
|
26
|
Wang L, Chen B, Wang Y, Sun N, Lu C, Qian
R and Hua L: hClock gene expression in human colorectal carcinoma.
Mol Med Rep. 8:1017–1022. 2013.PubMed/NCBI
|
|
27
|
Wang Y, Qian R, Sun N, Lu C, Chen Z and
Hua L: Circadian gene hClock enhances proliferation and inhibits
apoptosis of human colorectal carcinoma cells in vitro and in vivo.
Mol Med Rep. 11:4204–4210. 2015.PubMed/NCBI
|
|
28
|
Kubens BS and Zänker KS: Differences in
the migration capacity of primary human colon carcinoma cells
(SW480) and their lymph node metastatic derivatives (SW620). Cancer
Lett. 131:55–64. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang MH, Hsu DS, Wang HW, Wang HJ, Lan HY,
Yang WH, Huang CH, Kao SY, Tzeng CH, Tai SK, et al: Bmi1 is
essential in Twist1-induced epithelial-mesenchymal transition. Nat
Cell Biol. 12:982–992. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zeisberg M and Neilson EG: Biomarkers for
epithelial-mesenchymal transitions. J Clin Invest. 119:1429–1437.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Koyanagi S, Kuramoto Y, Nakagawa H,
Aramaki H, Ohdo S, Soeda S and Shimeno H: A molecular mechanism
regulating circadian expression of vascular endothelial growth
factor in tumor cells. Cancer Res. 63:7277–7283. 2003.PubMed/NCBI
|
|
33
|
Jensen LD and Cao Y: Clock controls
angiogenesis. Cell Cycle. 12:405–408. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Singh R, Lillard JW Jr and Singh S:
Chemokines: Key players in cancer progression and metastasis. Front
Biosci (Schol Ed). 3:1569–1582. 2011.
|
|
35
|
Hwang-Verslues WW, Chang PH, Jeng YM, Kuo
WH, Chiang PH, Chang YC, Hsieh TH, Su FY, Lin LC, Abbondante S, et
al: Loss of corepressor PER2 under hypoxia up-regulates
OCT1-mediated EMT gene expression and enhances tumor malignancy.
Proc Natl Acad Sci USA. 110:12331–12336. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li A, Lin X, Tan X, Yin B, Han W, Zhao J,
Yuan J, Qiang B and Peng X: Circadian gene Clock contributes to
cell proliferation and migration of glioma and is directly
regulated by tumor-suppressive miR-124. FEBS Lett. 587:2455–2460.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jensen LD: The circadian clock and hypoxia
in tumor cell de-differentiation and metastasis. Biochim Biophys
Acta. 1850:1633–1641. 2015. View Article : Google Scholar
|
|
38
|
Geva E and Jaffe RB: Role of vascular
endothelial growth factor in ovarian physiology and pathology.
Fertil Steril. 74:429–438. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang GL and Semenza GL: Purification and
characterization of hypoxia-inducible factor 1. J Biol Chem.
270:1230–1237. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Folkman J: Tumor angiogenesis. Adv Cancer
Res. 43:175–203. 1985. View Article : Google Scholar : PubMed/NCBI
|
